TABLE 2.
Base‐case | Chemotherapy | Toripalimab | Incremental |
---|---|---|---|
Total costs ($) | 161,632 | 361,813 | 200,181 |
PFS‐costs of medication | 612 | 175,401 | 174,789 |
Costs of drug management | 9363 | 17,649 | 8286 |
Costs of disease management | 36,873 | 72,933 | 36,060 |
Costs of progressed disease | 83,407 | 63,231 | −20,176 |
Costs of adverse events | 21,356 | 23,974 | 2618 |
Costs of terminal care | 10,020 | 8625 | −1395 |
Total QALYs | 1.685 | 4.390 | 2.705 |
PFS‐QALYs | 0.506 | 1.063 | 0.557 |
PD‐QALYs | 1.179 | 3.327 | 2.148 |
Abbreviations: PD, progressive disease; PFS, progression‐free survival; QALY, quality‐adjusted life year.